Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine during cesarean delivery for prevention of postpartum depression
ChiCTR1900022464Phase 4Recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in postpartum depression (PPD) (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Edinburgh Postnatal Depression Scale. Started Apr 2019; status: recruiting.
02
Drugs
ketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR1900022464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022464.